The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Added Value of Gadoxetic Acid–enhanced Hepatobiliary Phase MR Imaging in the Diagnosis of Hepatocellular Carcinoma
Open accessAbstract
PURPOSE: To determine the added value of hepatobiliary phase images in gadoxetic acid-enhanced magnetic resonance (MR) imaging in the evaluation of hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Institutional review board approved this retrospective study and waived the informed consent. Fifty-nine patients with 84 HCCs underwent gadoxetic acid-enhanced MR examinations that included 20-minute delayed hepatobiliary phase imaging. MR imaging was performed with a 1.5-T system in 19 patients and a 3.0-T system in 40 patients. A total of 113 hepatic nodules were documented for analysis. Three radiologists independently reviewed two sets of MR images: set 1, unenhanced (T1- and T2-weighted) and gadoxetic acid-enhanced dynamic images; set 2, hepatobiliary phase images and unenhanced and gadoxetic acid-enhanced dynamic images. For each observer, the diagnostic accuracy was compared by using the area under the alternative free-response receiver operating characteristic curve (A(z)). Sensitivity and specificity were also calculated and compared between the two sets. RESULTS: For all observers, A(z) values were higher with the addition of the hepatobiliary phase. The observer who had the least experience in abdominal imaging (2 years) demonstrated significant improvement in A(z), from 0.895 in set 1 to 0.951 in set 2 (P = .049). Sensitivity increased with the addition of hepatobiliary phase images but did not reach statistical significance. Nine HCCs (10.7%) in six patients (10.1%) were seen only on hepatobiliary phase images. CONCLUSION: Hepatobiliary phase images obtained after gadoxetic acid-enhanced dynamic MR imaging may improve diagnosis of HCC and assist in surgical planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Hamm, B., Staks, T., Mühler, A., Bollow, M., Taupitz, M., Frenzel, T., Wolf, K. J., Weinmann, H. J., & Lange, L. (1995) · Radiology · doi:10.1148/radiology.195.3.7754011 · Cited by 575
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl, T. J., Kümmel, S., Hammerstingl, R., Schellenbeck, M., Schumacher, G., Balzer, T., Schwarz, W., Müller, P. K., Bechstein, W. O., Mack, M. G., et al. (1996) · Radiology · doi:10.1148/radiology.200.1.8657946 · Cited by 453
Huppertz, A., Balzer, T., Blakeborough, A., Breuer, J., Giovagnoni, A., Heinz-Peer, G., Laniado, M., Manfredi, R. M., Mathieu, D. G., Mueller, D., et al. (2004) · Radiology · doi:10.1148/radiol.2301020269 · Cited by 396
For the European EOB-study group, Hammerstingl, R., Huppertz, A., Breuer, J., Balzer, T., Blakeborough, A., Carter, R., Fusté, L. C., Heinz-Peer, G., Judmaier, W., et al. (2008) · European Radiology · doi:10.1007/s00330-007-0716-9 · Cited by 384
Huppertz, A., Haraida, S., Kraus, A., Zech, C. J., Scheidler, J., Breuer, J., Helmberger, T. K., & Reiser, M. F. (2005) · Radiology · doi:10.1148/radiol.2342040278 · Cited by 370
Kim, S. H., Kim, S. H., Lee, J., Kim, M. J., Jeon, Y. H., Park, Y., Choi, D., Lee, W. J., & Lim, H. K. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.08.1262 · Cited by 311
Self-citationPhase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer, P., Rummeny, E. J., Shamsi, K., Balzer, T., Daldrup, H. E., Tombach, B., Hesse, T., Berns, T., & Peters, P. E. (1996) · Radiology · doi:10.1148/radiology.199.1.8633143 · Cited by 309
Yamashita, Y., Mitsuzaki, K., Yi, T., Ogata, I., Nishiharu, T., Urata, J., & Takahashi, M. (1996) · Radiology · doi:10.1148/radiology.200.1.8657948 · Cited by 272
A new lipophilic gadolinium chelate as a tissue‐specific contrast medium for MRI
Weinmann, H. ‐., Schuhmann‐Giampieri, G., Schmitt‐Willich, H., Vogler, H., Frenzel, T., & Gries, H. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910220214 · Cited by 237
Cited by
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Choi, J.-Y., Lee, J.-M., & Sirlin, C. B. (2014) · Radiology · doi:10.1148/radiol.14132362 · Cited by 526
Self-citationLee, Y. J., Lee, J. M., Lee, J. S., Lee, H. Y., Park, B. H., Kim, Y. H., Han, J. K., & Choi, B. I. (2015) · Radiology · doi:10.1148/radiol.14140690 · Cited by 526
Primovist, Eovist: What to expect?
Van Beers, B. E., Pastor, C. M., & Hussain, H. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.031 · Cited by 407
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
Sano, K., Ichikawa, T., Motosugi, U., Sou, H., Muhi, A. M., Matsuda, M., Nakano, M., Sakamoto, M., Nakazawa, T., Asakawa, M., et al. (2011) · Radiology · doi:10.1148/radiol.11101840 · Cited by 353
Metadata
- Authors
- Ahn, S. S., Kim, M.-J., Lim, J. S., Hong, H.-S., Chung, Y. E., & Choi, J.-Y.
- Venue
- Radiology
- Published
- 2010-05
- Volume
- 255
- Issue
- 2
- Pages
- 459-466
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2000928973
- Cited by
- 331
- References
- 16
- FWCI
- 27.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Added Value of Gadoxetic Acid–enhanced Hepatobiliary Phase MR Imaging in the Diagnosis of Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1148/radiol.10091388
- The paper
- Ahn, S. S., Kim, M.-J., Lim, J. S., Hong, H.-S., Chung, Y. E., & Choi, J.-Y. (2010). Added Value of Gadoxetic Acid–enhanced Hepatobiliary Phase MR Imaging in the Diagnosis of Hepatocellular Carcinoma. Radiology. https://doi.org/10.1148/radiol.10091388
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.